|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 CAD | -.--% |
|
+20.00% | -.--% |
HAVN Life Sciences Inc. reported earnings results for the full year ended April 30, 2022. For the full year, the company reported sales was CAD 0.276473 million. Net loss was CAD 22.44 million compared to CAD 30.38 million a year ago.
Basic loss per share from continuing operations was CAD 5.25 compared to CAD 15.51 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 632K | |
| +31.54% | 49.46B | |
| +1.06% | 42.58B | |
| +48.88% | 42.49B | |
| -5.26% | 29.09B | |
| +12.36% | 26.61B | |
| -23.61% | 18.64B | |
| +7.24% | 13.16B | |
| +30.84% | 12.55B | |
| +23.62% | 12.1B |
HAVN LIFE SCIENCES INC. 
